25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CBHD (Coloplast) Stock Analysis
Buy, Hold or Sell?

Let's analyze Coloplast together

I guess you are interested in Coloplast A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Coloplast’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Coloplast’s Price Targets

I'm going to help you getting a better view of Coloplast A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Coloplast A/S

I send you an email if I find something interesting about Coloplast A/S.

1. Quick Overview

1.1. Quick analysis of Coloplast (30 sec.)










1.2. What can you expect buying and holding a share of Coloplast? (30 sec.)

How much money do you get?

How much money do you get?
€3.40
When do you have the money?
1 year
How often do you get paid?
55.0%

What is your share worth?

Current worth
€10.07
Expected worth in 1 year
€10.49
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
€3.36
Return On Investment
4.1%

For what price can you sell your share?

Current Price per Share
€82.16
Expected price per share
€80.76 - €87.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Coloplast (5 min.)




Live pricePrice per Share (EOD)
€82.16
Intrinsic Value Per Share
€16.55 - €31.95
Total Value Per Share
€26.62 - €42.02

2.2. Growth of Coloplast (5 min.)




Is Coloplast growing?

Current yearPrevious yearGrowGrow %
How rich?$2.6b$2.1b$453.8m17.6%

How much money is Coloplast making?

Current yearPrevious yearGrowGrow %
Making money$1.3b$1.4b-$121.3m-9.3%
Net Profit Margin16.4%19.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Coloplast (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#22 / 164

Most Revenue
#21 / 164

Most Profit
#15 / 164
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Coloplast?

Welcome investor! Coloplast's management wants to use your money to grow the business. In return you get a share of Coloplast.

First you should know what it really means to hold a share of Coloplast. And how you can make/lose money.

Speculation

The Price per Share of Coloplast is €82.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Coloplast.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Coloplast, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €10.07. Based on the TTM, the Book Value Change Per Share is €0.10 per quarter. Based on the YOY, the Book Value Change Per Share is €1.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.74 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Coloplast.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps4.665.7%5.817.1%6.467.9%6.267.6%6.207.6%5.286.4%
Usd Book Value Change Per Share1.011.2%0.120.1%1.602.0%0.530.6%0.340.4%0.170.2%
Usd Dividend Per Share0.000.0%0.851.0%0.811.0%1.071.3%0.931.1%0.750.9%
Usd Total Gains Per Share1.011.2%0.971.2%2.412.9%1.601.9%1.271.5%0.921.1%
Usd Price Per Share111.46-124.03-127.51-126.79-139.52-116.45-
Price to Earnings Ratio5.97-5.40-4.94-5.10-5.68-5.08-
Price-to-Total Gains Ratio110.34-128.27-126.27-143.44-169.83-157.18-
Price to Book Ratio9.60-10.83-15.52-17.44-23.26-23.61-
Price-to-Total Gains Ratio110.34-128.27-126.27-143.44-169.83-157.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share94.697616
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.850.93
Usd Book Value Change Per Share0.120.34
Usd Total Gains Per Share0.971.27
Gains per Quarter (10 shares)9.6912.67
Gains per Year (10 shares)38.7650.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
134529371441
2681068742792
31021410711141143
41361914614855194
51702418518568245
62042922422282296
72383326325996347
827238302296109398
930643341333123449
1034048380370136500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%64.02.00.097.0%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%11.09.00.055.0%20.020.00.050.0%35.028.03.053.0%
Dividend per Share2.00.02.050.0%8.00.04.066.7%12.00.08.060.0%22.00.018.055.0%31.00.035.047.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%62.02.02.093.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Coloplast A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8760.104+746%1.391-37%0.458+91%0.296+196%0.150+484%
Book Value Per Share--10.0729.948+1%8.269+22%7.529+34%6.255+61%4.815+109%
Current Ratio--0.9540.911+5%0.681+40%0.868+10%0.896+7%0.988-3%
Debt To Asset Ratio--0.6550.6560%0.702-7%0.720-9%0.660-1%0.606+8%
Debt To Equity Ratio--1.9011.912-1%2.594-27%2.886-34%2.343-19%1.810+5%
Dividend Per Share---0.737-100%0.703-100%0.926-100%0.803-100%0.649-100%
Enterprise Value--17577726000.00020080084823.350-12%20457089503.913-14%20201515108.092-13%23321696942.348-25%19885726653.590-12%
Eps--4.0465.045-20%5.603-28%5.432-26%5.383-25%4.584-12%
Ev To Ebitda Ratio--2.0432.290-11%2.474-17%2.430-16%3.058-33%2.927-30%
Ev To Sales Ratio--0.6340.723-12%0.801-21%0.783-19%1.045-39%1.022-38%
Free Cash Flow Per Share--0.2570.725-65%0.164+56%0.444-42%0.483-47%0.489-47%
Free Cash Flow To Equity Per Share---0.099-0.050-50%1.224-108%0.411-124%0.582-117%0.315-131%
Gross Profit Margin---1.550-1.073-31%-0.623-60%-0.753-51%-0.549-65%-0.377-76%
Intrinsic Value_10Y_max--31.950----------
Intrinsic Value_10Y_min--16.547----------
Intrinsic Value_1Y_max--2.139----------
Intrinsic Value_1Y_min--1.766----------
Intrinsic Value_3Y_max--7.236----------
Intrinsic Value_3Y_min--5.245----------
Intrinsic Value_5Y_max--13.310----------
Intrinsic Value_5Y_min--8.629----------
Market Cap17037273377.280-28%21796180000.00024232878823.350-10%24520371503.913-11%24166664441.425-10%26228813542.348-17%21731951853.590+0%
Net Profit Margin--0.1320.164-20%0.195-32%0.185-29%0.204-35%0.199-34%
Operating Margin--0.2610.268-3%0.278-6%0.277-6%0.293-11%0.277-6%
Operating Ratio--0.7270.7290%0.724+0%0.722+1%0.705+3%0.693+5%
Pb Ratio8.157-18%9.60110.834-11%15.517-38%17.441-45%23.258-59%23.614-59%
Pe Ratio5.076-18%5.9755.399+11%4.937+21%5.100+17%5.676+5%5.079+18%
Price Per Share82.160-18%96.700107.613-10%110.625-13%110.000-12%121.045-20%101.033-4%
Price To Free Cash Flow Ratio79.977-18%94.13147.957+96%22.568+317%56.464+67%-234.698+349%-84.929+190%
Price To Total Gains Ratio93.750-18%110.341128.268-14%126.272-13%143.443-23%169.831-35%157.184-30%
Quick Ratio--0.5670.514+10%0.355+59%0.465+22%0.500+13%0.594-5%
Return On Assets--0.1380.175-21%0.210-34%0.213-35%0.340-59%0.416-67%
Return On Equity--0.4020.507-21%0.792-49%0.869-54%1.014-60%1.067-62%
Total Gains Per Share--0.8760.841+4%2.094-58%1.385-37%1.099-20%0.799+10%
Usd Book Value--2616664792.8002581952514.900+1%2128067279.400+23%1926795272.800+36%1582825815.300+65%1205195616.090+117%
Usd Book Value Change Per Share--1.0100.119+746%1.603-37%0.528+91%0.341+196%0.173+484%
Usd Book Value Per Share--11.60911.466+1%9.531+22%8.678+34%7.210+61%5.550+109%
Usd Dividend Per Share---0.850-100%0.810-100%1.068-100%0.926-100%0.748-100%
Usd Enterprise Value--20260086987.60023144305767.393-12%23578841362.210-14%23284266313.587-13%26880587895.750-25%22920288540.928-12%
Usd Eps--4.6645.815-20%6.457-28%6.261-26%6.204-25%5.284-12%
Usd Free Cash Flow--66721708.800188156763.300-65%40658541.300+64%112348340.300-41%120670534.920-45%120979431.720-45%
Usd Free Cash Flow Per Share--0.2960.836-65%0.189+56%0.511-42%0.557-47%0.563-47%
Usd Free Cash Flow To Equity Per Share---0.114-0.057-50%1.411-108%0.474-124%0.671-117%0.363-131%
Usd Market Cap19637161294.653-28%25122277068.00027930816131.793-10%28262180195.410-11%27854497435.187-10%30231330488.910-17%25048247706.448+0%
Usd Price Per Share94.698-18%111.456124.034-10%127.506-13%126.786-12%139.516-20%116.450-4%
Usd Profit--1051171200.0001309353600.000-20%1430664750.000-27%1374475500.000-24%1346236800.000-22%1137155160.000-8%
Usd Revenue--7987518000.0008008841100.0000%7355316900.000+9%7458570650.000+7%6728821170.000+19%5706868380.000+40%
Usd Total Gains Per Share--1.0100.969+4%2.413-58%1.596-37%1.267-20%0.921+10%
 EOD+4 -4MRQTTM+14 -26YOY+13 -273Y+12 -285Y+12 -2810Y+12 -28

3.3 Fundamental Score

Let's check the fundamental score of Coloplast A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.076
Price to Book Ratio (EOD)Between0-18.157
Net Profit Margin (MRQ)Greater than00.132
Operating Margin (MRQ)Greater than00.261
Quick Ratio (MRQ)Greater than10.567
Current Ratio (MRQ)Greater than10.954
Debt to Asset Ratio (MRQ)Less than10.655
Debt to Equity Ratio (MRQ)Less than11.901
Return on Equity (MRQ)Greater than0.150.402
Return on Assets (MRQ)Greater than0.050.138
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Coloplast A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.346
Ma 20Greater thanMa 5084.727
Ma 50Greater thanMa 10087.868
Ma 100Greater thanMa 20094.968
OpenGreater thanClose82.320
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Fundamental data was last updated by Penke on 2025-06-17 22:57:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Coloplast earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 13.2%Β means thatΒ €0.13 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Coloplast A/S:

  • The MRQ is 13.2%. The company is making a huge profit. +2
  • The TTM is 16.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.2%TTM16.4%-3.2%
TTM16.4%YOY19.5%-3.1%
TTM16.4%5Y20.4%-4.0%
5Y20.4%10Y19.9%+0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ13.2%5.1%+8.1%
TTM16.4%4.6%+11.8%
YOY19.5%6.5%+13.0%
3Y18.5%6.8%+11.7%
5Y20.4%6.1%+14.3%
10Y19.9%6.9%+13.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Coloplast is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • 13.8% Return on Assets means thatΒ Coloplast generatedΒ €0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Coloplast A/S:

  • The MRQ is 13.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.8%TTM17.5%-3.6%
TTM17.5%YOY21.0%-3.5%
TTM17.5%5Y34.0%-16.5%
5Y34.0%10Y41.6%-7.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ13.8%1.0%+12.8%
TTM17.5%0.9%+16.6%
YOY21.0%1.0%+20.0%
3Y21.3%1.1%+20.2%
5Y34.0%1.5%+32.5%
10Y41.6%1.5%+40.1%
4.3.1.3. Return on Equity

Shows how efficient Coloplast is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • 40.2% Return on Equity means Coloplast generated €0.40Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Coloplast A/S:

  • The MRQ is 40.2%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 50.7%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ40.2%TTM50.7%-10.5%
TTM50.7%YOY79.2%-28.5%
TTM50.7%5Y101.4%-50.8%
5Y101.4%10Y106.7%-5.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ40.2%2.2%+38.0%
TTM50.7%1.9%+48.8%
YOY79.2%2.0%+77.2%
3Y86.9%2.1%+84.8%
5Y101.4%3.1%+98.3%
10Y106.7%2.8%+103.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Coloplast A/S.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Coloplast is operatingΒ .

  • Measures how much profit Coloplast makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • An Operating Margin of 26.1%Β means the company generated €0.26 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Coloplast A/S:

  • The MRQ is 26.1%. The company is operating very efficient. +2
  • The TTM is 26.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ26.1%TTM26.8%-0.7%
TTM26.8%YOY27.8%-1.0%
TTM26.8%5Y29.3%-2.5%
5Y29.3%10Y27.7%+1.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ26.1%8.2%+17.9%
TTM26.8%6.0%+20.8%
YOY27.8%6.0%+21.8%
3Y27.7%6.5%+21.2%
5Y29.3%8.7%+20.6%
10Y27.7%9.2%+18.5%
4.3.2.2. Operating Ratio

Measures how efficient Coloplast is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.73 means that the operating costs are €0.73 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Coloplast A/S:

  • The MRQ is 0.727. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.729. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.727TTM0.729-0.001
TTM0.729YOY0.724+0.005
TTM0.7295Y0.705+0.023
5Y0.70510Y0.693+0.012
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7271.102-0.375
TTM0.7291.124-0.395
YOY0.7241.023-0.299
3Y0.7221.084-0.362
5Y0.7051.053-0.348
10Y0.6931.012-0.319
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Coloplast A/S.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Coloplast is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.95Β means the company has €0.95 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Coloplast A/S:

  • The MRQ is 0.954. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.911. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.954TTM0.911+0.044
TTM0.911YOY0.681+0.230
TTM0.9115Y0.896+0.015
5Y0.89610Y0.988-0.093
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9542.082-1.128
TTM0.9112.114-1.203
YOY0.6812.427-1.746
3Y0.8682.501-1.633
5Y0.8962.652-1.756
10Y0.9882.617-1.629
4.4.3.2. Quick Ratio

Measures if Coloplast is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.57Β means the company can pay off €0.57 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Coloplast A/S:

  • The MRQ is 0.567. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.514. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.514+0.052
TTM0.514YOY0.355+0.159
TTM0.5145Y0.500+0.014
5Y0.50010Y0.594-0.093
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5670.881-0.314
TTM0.5141.010-0.496
YOY0.3551.108-0.753
3Y0.4651.256-0.791
5Y0.5001.468-0.968
10Y0.5941.605-1.011
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Coloplast A/S.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ColoplastΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Coloplast to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.66Β means that Coloplast assets areΒ financed with 65.5% credit (debt) and the remaining percentage (100% - 65.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Coloplast A/S:

  • The MRQ is 0.655. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.656. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.655TTM0.6560.000
TTM0.656YOY0.702-0.046
TTM0.6565Y0.660-0.005
5Y0.66010Y0.606+0.054
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6550.386+0.269
TTM0.6560.390+0.266
YOY0.7020.357+0.345
3Y0.7200.350+0.370
5Y0.6600.357+0.303
10Y0.6060.374+0.232
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Coloplast is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 190.1% means that company has €1.90 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Coloplast A/S:

  • The MRQ is 1.901. The company is just able to pay all its debts with equity.
  • The TTM is 1.912. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.901TTM1.912-0.011
TTM1.912YOY2.594-0.682
TTM1.9125Y2.343-0.431
5Y2.34310Y1.810+0.533
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9010.599+1.302
TTM1.9120.601+1.311
YOY2.5940.558+2.036
3Y2.8860.578+2.308
5Y2.3430.569+1.774
10Y1.8100.664+1.146
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Coloplast generates.

  • Above 15 is considered overpriced butΒ always compareΒ Coloplast to theΒ Medical Instruments & Supplies industry mean.
  • A PE ratio of 5.97 means the investor is paying €5.97Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Coloplast A/S:

  • The EOD is 5.076. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.975. Based on the earnings, the company is cheap. +2
  • The TTM is 5.399. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.076MRQ5.975-0.898
MRQ5.975TTM5.399+0.576
TTM5.399YOY4.937+0.462
TTM5.3995Y5.676-0.277
5Y5.67610Y5.079+0.597
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD5.07614.241-9.165
MRQ5.97513.784-7.809
TTM5.39914.997-9.598
YOY4.93717.388-12.451
3Y5.10018.496-13.396
5Y5.67620.962-15.286
10Y5.07921.679-16.600
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Coloplast A/S:

  • The EOD is 79.977. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 94.131. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 47.957. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD79.977MRQ94.131-14.154
MRQ94.131TTM47.957+46.174
TTM47.957YOY22.568+25.388
TTM47.9575Y-234.698+282.654
5Y-234.69810Y-84.929-149.768
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD79.97710.525+69.452
MRQ94.1319.748+84.383
TTM47.95710.621+37.336
YOY22.5689.030+13.538
3Y56.4644.559+51.905
5Y-234.6985.662-240.360
10Y-84.929-0.159-84.770
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Coloplast is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 9.60 means the investor is paying €9.60Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Coloplast A/S:

  • The EOD is 8.157. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.601. Based on the equity, the company is overpriced. -1
  • The TTM is 10.834. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.157MRQ9.601-1.444
MRQ9.601TTM10.834-1.233
TTM10.834YOY15.517-4.683
TTM10.8345Y23.258-12.424
5Y23.25810Y23.614-0.356
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD8.1572.547+5.610
MRQ9.6012.495+7.106
TTM10.8342.643+8.191
YOY15.5172.737+12.780
3Y17.4412.824+14.617
5Y23.2583.660+19.598
10Y23.6144.154+19.460
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets49,152,000
Total Liabilities32,210,000
Total Stockholder Equity16,942,000
 As reported
Total Liabilities 32,210,000
Total Stockholder Equity+ 16,942,000
Total Assets = 49,152,000

Assets

Total Assets49,152,000
Total Current Assets10,467,000
Long-term Assets38,685,000
Total Current Assets
Cash And Cash Equivalents 729,000
Net Receivables 5,485,000
Inventory 3,797,000
Other Current Assets 456,000
Total Current Assets  (as reported)10,467,000
Total Current Assets  (calculated)10,467,000
+/-0
Long-term Assets
Property Plant Equipment 6,904,000
Long-term Assets Other 121,000
Long-term Assets  (as reported)38,685,000
Long-term Assets  (calculated)7,025,000
+/- 31,660,000

Liabilities & Shareholders' Equity

Total Current Liabilities10,967,000
Long-term Liabilities21,243,000
Total Stockholder Equity16,942,000
Total Current Liabilities
Short-term Debt 6,935,000
Short Long Term Debt 6,673,000
Accounts payable 1,211,000
Other Current Liabilities 2,225,000
Total Current Liabilities  (as reported)10,967,000
Total Current Liabilities  (calculated)17,044,000
+/- 6,077,000
Long-term Liabilities
Long term Debt 16,565,000
Capital Lease Obligations 1,026,000
Long-term Liabilities Other 7,000
Long-term Liabilities  (as reported)21,243,000
Long-term Liabilities  (calculated)17,598,000
+/- 3,645,000
Total Stockholder Equity
Common Stock228,000
Retained Earnings 16,285,000
Other Stockholders Equity 429,000
Total Stockholder Equity (as reported)16,942,000
Total Stockholder Equity (calculated)16,942,000
+/-0
Other
Capital Stock228,000
Cash and Short Term Investments 729,000
Common Stock Shares Outstanding 225,400
Liabilities and Stockholders Equity 49,152,000
Net Debt 23,535,000
Net Invested Capital 40,180,000
Net Working Capital -500,000
Property Plant and Equipment Gross 6,904,000
Short Long Term Debt Total 24,264,000



6.2. Balance Sheets Structured

Currency in DKK. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
0
0
0
7,963,000
7,545,000
7,620,000
7,912,000
7,771,000
8,116,000
8,228,000
8,493,000
9,218,000
8,916,000
9,300,000
9,980,000
10,176,000
9,773,000
10,066,000
8,637,000
9,364,000
8,403,000
9,278,000
9,121,000
10,379,000
9,663,000
10,620,000
9,945,000
10,817,000
10,810,000
10,602,000
11,280,000
11,007,000
12,883,000
12,511,000
12,247,000
12,050,000
12,193,000
12,751,000
12,667,000
11,769,000
12,113,000
12,292,000
12,551,000
12,732,000
13,223,000
13,528,000
13,315,000
13,499,000
14,926,000
15,249,000
15,458,000
15,841,000
16,188,000
35,170,000
34,956,000
35,221,000
35,302,000
35,087,000
35,087,000
48,159,000
48,591,000
48,140,000
48,580,000
48,073,000
48,338,000
49,152,000
49,152,00048,338,00048,073,00048,580,00048,140,00048,591,00048,159,00035,087,00035,087,00035,302,00035,221,00034,956,00035,170,00016,188,00015,841,00015,458,00015,249,00014,926,00013,499,00013,315,00013,528,00013,223,00012,732,00012,551,00012,292,00012,113,00011,769,00012,667,00012,751,00012,193,00012,050,00012,247,00012,511,00012,883,00011,007,00011,280,00010,602,00010,810,00010,817,0009,945,00010,620,0009,663,00010,379,0009,121,0009,278,0008,403,0009,364,0008,637,00010,066,0009,773,00010,176,0009,980,0009,300,0008,916,0009,218,0008,493,0008,228,0008,116,0007,771,0007,912,0007,620,0007,545,0007,963,000000
   > Total Current Assets 
0
0
0
3,369,000
2,997,000
3,007,000
3,188,000
3,353,000
3,491,000
3,775,000
4,145,000
4,965,000
4,664,000
5,128,000
5,720,000
5,969,000
5,654,000
5,975,000
4,551,000
5,366,000
4,426,000
5,095,000
4,972,000
6,047,000
5,251,000
5,884,000
5,338,000
5,765,000
5,733,000
6,009,000
6,646,000
6,164,000
6,915,000
6,608,000
6,518,000
6,194,000
6,322,000
6,641,000
6,494,000
5,590,000
5,929,000
6,097,000
6,415,000
6,359,000
6,361,000
6,709,000
6,490,000
6,489,000
6,640,000
6,707,000
6,827,000
6,994,000
7,284,000
8,169,000
8,772,000
9,279,000
9,323,000
9,673,000
9,673,000
9,937,000
10,069,000
10,391,000
10,640,000
10,444,000
10,366,000
10,467,000
10,467,00010,366,00010,444,00010,640,00010,391,00010,069,0009,937,0009,673,0009,673,0009,323,0009,279,0008,772,0008,169,0007,284,0006,994,0006,827,0006,707,0006,640,0006,489,0006,490,0006,709,0006,361,0006,359,0006,415,0006,097,0005,929,0005,590,0006,494,0006,641,0006,322,0006,194,0006,518,0006,608,0006,915,0006,164,0006,646,0006,009,0005,733,0005,765,0005,338,0005,884,0005,251,0006,047,0004,972,0005,095,0004,426,0005,366,0004,551,0005,975,0005,654,0005,969,0005,720,0005,128,0004,664,0004,965,0004,145,0003,775,0003,491,0003,353,0003,188,0003,007,0002,997,0003,369,000000
       Cash And Cash Equivalents 
0
0
0
629,000
278,000
237,000
335,000
475,000
350,000
381,000
454,000
1,318,000
848,000
1,496,000
1,914,000
1,973,000
988,000
1,417,000
617,000
1,504,000
462,000
454,000
404,000
971,000
428,000
656,000
644,000
881,000
412,000
402,000
424,000
546,000
545,000
442,000
314,000
314,000
505,000
608,000
450,000
297,000
432,000
312,000
444,000
356,000
516,000
498,000
411,000
323,000
435,000
418,000
447,000
448,000
642,000
517,000
414,000
671,000
628,000
855,000
855,000
911,000
916,000
889,000
887,000
788,000
906,000
729,000
729,000906,000788,000887,000889,000916,000911,000855,000855,000628,000671,000414,000517,000642,000448,000447,000418,000435,000323,000411,000498,000516,000356,000444,000312,000432,000297,000450,000608,000505,000314,000314,000442,000545,000546,000424,000402,000412,000881,000644,000656,000428,000971,000404,000454,000462,0001,504,000617,0001,417,000988,0001,973,0001,914,0001,496,000848,0001,318,000454,000381,000350,000475,000335,000237,000278,000629,000000
       Short-term Investments 
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
180,000
471,000
568,000
659,000
456,000
608,000
645,000
1,337,000
1,149,000
335,000
367,000
475,000
632,000
401,000
619,000
200,000
216,000
210,000
519,000
201,000
200,000
200,000
489,000
379,000
334,000
313,000
315,000
316,000
311,000
311,000
310,000
305,000
308,000
311,000
313,000
304,000
302,000
262,000
262,000
257,000
257,000
228,000
226,000
222,000
220,000
219,000
210,000
16,000
16,000
0
0
0
0
0
0
0
0
0000000016,00016,000210,000219,000220,000222,000226,000228,000257,000257,000262,000262,000302,000304,000313,000311,000308,000305,000310,000311,000311,000316,000315,000313,000334,000379,000489,000200,000200,000201,000519,000210,000216,000200,000619,000401,000632,000475,000367,000335,0001,149,0001,337,000645,000608,000456,000659,000568,000471,000180,0001,0001,0001,0001,0001,0001,000000
       Net Receivables 
0
0
0
0
0
0
0
0
1,970,000
0
0
0
0
0
0
0
1,834,000
1,961,000
2,027,000
1,970,000
1,994,000
2,070,000
2,142,000
2,210,000
2,285,000
2,507,000
2,480,000
2,467,000
2,510,000
2,663,000
2,769,000
2,679,000
2,689,000
2,819,000
2,845,000
2,890,000
2,755,000
2,894,000
2,970,000
2,877,000
2,894,000
3,113,000
3,227,000
3,153,000
2,982,000
3,269,000
2,997,000
2,934,000
2,916,000
3,108,000
3,142,000
3,212,000
3,215,000
3,648,000
3,837,000
3,940,000
3,953,000
3,988,000
4,072,000
4,315,000
4,392,000
4,641,000
4,835,000
5,041,000
4,963,000
5,485,000
5,485,0004,963,0005,041,0004,835,0004,641,0004,392,0004,315,0004,072,0003,988,0003,953,0003,940,0003,837,0003,648,0003,215,0003,212,0003,142,0003,108,0002,916,0002,934,0002,997,0003,269,0002,982,0003,153,0003,227,0003,113,0002,894,0002,877,0002,970,0002,894,0002,755,0002,890,0002,845,0002,819,0002,689,0002,679,0002,769,0002,663,0002,510,0002,467,0002,480,0002,507,0002,285,0002,210,0002,142,0002,070,0001,994,0001,970,0002,027,0001,961,0001,834,00000000001,970,00000000000
       Other Current Assets 
0
0
0
1,753,000
1,803,000
1,788,000
1,890,000
1,918,000
2,156,000
2,182,000
2,220,000
2,133,000
2,200,000
2,231,000
2,236,000
2,343,000
2,305,000
2,349,000
2,512,000
456,000
413,000
776,000
807,000
925,000
954,000
1,038,000
520,000
425,000
1,105,000
1,289,000
1,751,000
932,000
1,676,000
1,271,000
1,304,000
983,000
1,060,000
1,149,000
1,084,000
381,000
480,000
495,000
519,000
604,000
642,000
725,000
704,000
743,000
801,000
635,000
632,000
680,000
708,000
914,000
990,000
1,012,000
1,048,000
1,179,000
1,189,000
1,189,000
1,242,000
1,299,000
1,242,000
943,000
824,000
456,000
456,000824,000943,0001,242,0001,299,0001,242,0001,189,0001,189,0001,179,0001,048,0001,012,000990,000914,000708,000680,000632,000635,000801,000743,000704,000725,000642,000604,000519,000495,000480,000381,0001,084,0001,149,0001,060,000983,0001,304,0001,271,0001,676,000932,0001,751,0001,289,0001,105,000425,000520,0001,038,000954,000925,000807,000776,000413,000456,0002,512,0002,349,0002,305,0002,343,0002,236,0002,231,0002,200,0002,133,0002,220,0002,182,0002,156,0001,918,0001,890,0001,788,0001,803,0001,753,000000
   > Long-term Assets 
0
0
0
4,594,000
4,548,000
4,613,000
4,724,000
4,418,000
4,625,000
4,453,000
4,348,000
4,253,000
4,252,000
4,172,000
4,260,000
4,207,000
4,119,000
4,091,000
4,086,000
3,998,000
3,977,000
4,183,000
4,149,000
4,332,000
4,412,000
4,736,000
4,607,000
5,052,000
5,077,000
4,593,000
4,634,000
4,843,000
5,968,000
5,903,000
5,729,000
5,856,000
5,871,000
6,110,000
6,173,000
6,179,000
6,184,000
6,195,000
6,136,000
6,373,000
6,862,000
6,819,000
6,825,000
7,010,000
8,286,000
8,542,000
8,631,000
8,847,000
8,904,000
27,001,000
26,184,000
25,942,000
25,979,000
25,414,000
25,414,000
38,222,000
38,522,000
37,749,000
37,940,000
37,629,000
37,972,000
38,685,000
38,685,00037,972,00037,629,00037,940,00037,749,00038,522,00038,222,00025,414,00025,414,00025,979,00025,942,00026,184,00027,001,0008,904,0008,847,0008,631,0008,542,0008,286,0007,010,0006,825,0006,819,0006,862,0006,373,0006,136,0006,195,0006,184,0006,179,0006,173,0006,110,0005,871,0005,856,0005,729,0005,903,0005,968,0004,843,0004,634,0004,593,0005,077,0005,052,0004,607,0004,736,0004,412,0004,332,0004,149,0004,183,0003,977,0003,998,0004,086,0004,091,0004,119,0004,207,0004,260,0004,172,0004,252,0004,253,0004,348,0004,453,0004,625,0004,418,0004,724,0004,613,0004,548,0004,594,000000
       Property Plant Equipment 
0
0
0
2,635,000
2,596,000
2,601,000
2,596,000
5,827,000
2,435,000
2,392,000
2,349,000
2,266,000
2,094,000
2,240,000
2,092,000
2,286,000
2,257,000
2,218,000
2,267,000
2,286,000
2,317,000
2,309,000
2,368,000
2,462,000
2,516,000
2,712,000
2,669,000
2,705,000
2,727,000
2,717,000
2,762,000
2,925,000
2,919,000
2,928,000
2,937,000
3,072,000
3,134,000
3,125,000
3,151,000
3,169,000
3,175,000
3,179,000
3,146,000
3,249,000
3,786,000
3,760,000
3,798,000
3,926,000
4,045,000
4,168,000
4,232,000
4,386,000
4,421,000
4,884,000
5,151,000
5,396,000
5,617,000
5,793,000
5,793,000
5,979,000
6,073,000
6,319,000
6,434,000
6,571,000
6,755,000
6,904,000
6,904,0006,755,0006,571,0006,434,0006,319,0006,073,0005,979,0005,793,0005,793,0005,617,0005,396,0005,151,0004,884,0004,421,0004,386,0004,232,0004,168,0004,045,0003,926,0003,798,0003,760,0003,786,0003,249,0003,146,0003,179,0003,175,0003,169,0003,151,0003,125,0003,134,0003,072,0002,937,0002,928,0002,919,0002,925,0002,762,0002,717,0002,727,0002,705,0002,669,0002,712,0002,516,0002,462,0002,368,0002,309,0002,317,0002,286,0002,267,0002,218,0002,257,0002,286,0002,092,0002,240,0002,094,0002,266,0002,349,0002,392,0002,435,0005,827,0002,596,0002,601,0002,596,0002,635,000000
       Goodwill 
0
0
0
629,000
639,000
674,000
732,000
670,000
785,000
746,000
736,000
737,000
764,000
743,000
783,000
767,000
750,000
768,000
757,000
735,000
723,000
726,000
730,000
772,000
799,000
877,000
847,000
842,000
862,000
834,000
847,000
844,000
1,800,000
1,772,000
1,665,000
1,724,000
0
0
0
1,984,000
0
0
0
2,030,000
0
0
0
1,976,000
0
0
0
2,028,000
0
10,130,000
11,808,000
11,808,000
-199,000
-747,000
0
19,974,000
0
0
0
19,375,000
0
0
0019,375,00000019,974,0000-747,000-199,00011,808,00011,808,00010,130,00002,028,0000001,976,0000002,030,0000001,984,0000001,724,0001,665,0001,772,0001,800,000844,000847,000834,000862,000842,000847,000877,000799,000772,000730,000726,000723,000735,000757,000768,000750,000767,000783,000743,000764,000737,000736,000746,000785,000670,000732,000674,000639,000629,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000
11,000
11,000
11,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000011,00011,00011,00013,00000000000000000000000000000
       Intangible Assets 
0
0
0
1,179,000
1,162,000
1,184,000
1,220,000
123,000
1,201,000
1,114,000
1,064,000
1,065,000
1,193,000
989,000
1,179,000
916,000
883,000
867,000
827,000
781,000
742,000
713,000
690,000
709,000
705,000
740,000
697,000
669,000
652,000
604,000
583,000
553,000
732,000
686,000
619,000
571,000
2,248,000
2,495,000
2,533,000
534,000
2,516,000
2,517,000
2,486,000
472,000
2,459,000
2,456,000
2,419,000
388,000
3,524,000
3,614,000
3,634,000
1,623,000
3,677,000
11,069,000
8,469,000
8,469,000
19,802,000
19,603,000
18,856,000
11,281,000
31,440,000
30,403,000
30,573,000
10,957,000
0
0
0010,957,00030,573,00030,403,00031,440,00011,281,00018,856,00019,603,00019,802,0008,469,0008,469,00011,069,0003,677,0001,623,0003,634,0003,614,0003,524,000388,0002,419,0002,456,0002,459,000472,0002,486,0002,517,0002,516,000534,0002,533,0002,495,0002,248,000571,000619,000686,000732,000553,000583,000604,000652,000669,000697,000740,000705,000709,000690,000713,000742,000781,000827,000867,000883,000916,0001,179,000989,0001,193,0001,065,0001,064,0001,114,0001,201,000123,0001,220,0001,184,0001,162,0001,179,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
669,000
669,000
711,000
709,000
743,000
739,000
0
0
1,891,000
693,000
0
0
0
0
0
0
0
0
0
000000000693,0001,891,00000739,000743,000709,000711,000669,000669,00000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
5,113,000
4,666,000
4,540,000
4,790,000
4,319,000
4,594,000
4,454,000
4,506,000
4,740,000
4,476,000
4,332,000
4,582,000
4,134,000
3,852,000
3,716,000
2,482,000
2,595,000
2,313,000
3,431,000
3,698,000
4,096,000
4,268,000
4,147,000
4,152,000
6,111,000
6,784,000
5,679,000
6,781,000
5,939,000
8,669,000
7,447,000
7,289,000
6,098,000
7,482,000
7,375,000
7,465,000
5,351,000
6,921,000
6,119,000
6,612,000
5,819,000
7,772,000
6,942,000
6,953,000
6,093,000
9,156,000
8,313,000
8,531,000
7,673,000
9,769,000
27,897,000
26,664,000
29,316,000
28,268,000
28,597,000
28,597,000
30,860,000
33,466,000
31,940,000
32,056,000
30,131,000
32,877,000
32,210,000
32,210,00032,877,00030,131,00032,056,00031,940,00033,466,00030,860,00028,597,00028,597,00028,268,00029,316,00026,664,00027,897,0009,769,0007,673,0008,531,0008,313,0009,156,0006,093,0006,953,0006,942,0007,772,0005,819,0006,612,0006,119,0006,921,0005,351,0007,465,0007,375,0007,482,0006,098,0007,289,0007,447,0008,669,0005,939,0006,781,0005,679,0006,784,0006,111,0004,152,0004,147,0004,268,0004,096,0003,698,0003,431,0002,313,0002,595,0002,482,0003,716,0003,852,0004,134,0004,582,0004,332,0004,476,0004,740,0004,506,0004,454,0004,594,0004,319,0004,790,0004,540,0004,666,0005,113,000000
   > Total Current Liabilities 
0
0
0
1,987,000
1,804,000
1,898,000
2,239,000
2,058,000
1,801,000
1,670,000
1,714,000
2,087,000
1,904,000
1,751,000
3,415,000
3,708,000
3,406,000
3,263,000
2,061,000
2,266,000
1,980,000
2,041,000
2,935,000
3,529,000
3,815,000
3,814,000
3,845,000
4,578,000
5,546,000
4,781,000
6,317,000
5,309,000
8,220,000
6,982,000
6,836,000
5,425,000
6,826,000
6,701,000
6,800,000
4,708,000
6,281,000
5,453,000
5,955,000
4,942,000
6,648,000
5,894,000
5,923,000
4,979,000
7,782,000
6,822,000
7,116,000
6,314,000
8,477,000
24,811,000
7,336,000
10,482,000
9,433,000
9,838,000
9,838,000
16,311,000
18,918,000
17,305,000
12,465,000
10,204,000
12,765,000
10,967,000
10,967,00012,765,00010,204,00012,465,00017,305,00018,918,00016,311,0009,838,0009,838,0009,433,00010,482,0007,336,00024,811,0008,477,0006,314,0007,116,0006,822,0007,782,0004,979,0005,923,0005,894,0006,648,0004,942,0005,955,0005,453,0006,281,0004,708,0006,800,0006,701,0006,826,0005,425,0006,836,0006,982,0008,220,0005,309,0006,317,0004,781,0005,546,0004,578,0003,845,0003,814,0003,815,0003,529,0002,935,0002,041,0001,980,0002,266,0002,061,0003,263,0003,406,0003,708,0003,415,0001,751,0001,904,0002,087,0001,714,0001,670,0001,801,0002,058,0002,239,0001,898,0001,804,0001,987,000000
       Short-term Debt 
0
0
0
233,000
264,000
335,000
345,000
172,000
207,000
174,000
113,000
98,000
156,000
456,000
1,343,000
1,296,000
1,335,000
1,311,000
146,000
111,000
129,000
130,000
154,000
92,000
367,000
467,000
779,000
100,000
391,000
25,000
923,000
-4,153,000
-1,937,000
-1,084,000
-1,211,000
-2,023,000
-477,000
286,000
-188,000
1,270,000
3,045,000
2,592,000
2,848,000
1,074,000
3,156,000
2,767,000
2,671,000
1,317,000
4,194,000
3,670,000
3,848,000
2,337,000
4,606,000
20,601,000
3,719,000
1,853,000
5,168,000
4,606,000
5,052,000
7,345,000
9,421,000
12,169,000
7,212,000
5,338,000
7,446,000
6,935,000
6,935,0007,446,0005,338,0007,212,00012,169,0009,421,0007,345,0005,052,0004,606,0005,168,0001,853,0003,719,00020,601,0004,606,0002,337,0003,848,0003,670,0004,194,0001,317,0002,671,0002,767,0003,156,0001,074,0002,848,0002,592,0003,045,0001,270,000-188,000286,000-477,000-2,023,000-1,211,000-1,084,000-1,937,000-4,153,000923,00025,000391,000100,000779,000467,000367,00092,000154,000130,000129,000111,000146,0001,311,0001,335,0001,296,0001,343,000456,000156,00098,000113,000174,000207,000172,000345,000335,000264,000233,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
779,000
100,000
391,000
25,000
0
0
0
0
0
0
0
0
0
0
0
2,584,000
2,840,000
1,066,000
2,989,000
2,616,000
2,515,000
1,111,000
4,021,000
3,501,000
3,683,000
2,160,000
4,435,000
20,392,000
3,514,000
1,644,000
4,965,000
4,392,000
4,834,000
7,115,000
9,192,000
11,918,000
6,960,000
5,085,000
7,195,000
6,673,000
6,673,0007,195,0005,085,0006,960,00011,918,0009,192,0007,115,0004,834,0004,392,0004,965,0001,644,0003,514,00020,392,0004,435,0002,160,0003,683,0003,501,0004,021,0001,111,0002,515,0002,616,0002,989,0001,066,0002,840,0002,584,0000000000000025,000391,000100,000779,00000000000000000000000000000
       Accounts payable 
0
0
0
428,000
366,000
344,000
414,000
455,000
1,378,000
428,000
368,000
420,000
399,000
379,000
368,000
478,000
352,000
419,000
433,000
418,000
367,000
430,000
454,000
566,000
396,000
503,000
448,000
591,000
441,000
441,000
525,000
697,000
512,000
566,000
527,000
675,000
550,000
615,000
659,000
751,000
636,000
664,000
673,000
859,000
679,000
664,000
623,000
814,000
563,000
572,000
531,000
1,036,000
597,000
755,000
826,000
1,242,000
964,000
1,136,000
1,070,000
1,294,000
1,162,000
1,226,000
1,184,000
1,519,000
1,130,000
1,211,000
1,211,0001,130,0001,519,0001,184,0001,226,0001,162,0001,294,0001,070,0001,136,000964,0001,242,000826,000755,000597,0001,036,000531,000572,000563,000814,000623,000664,000679,000859,000673,000664,000636,000751,000659,000615,000550,000675,000527,000566,000512,000697,000525,000441,000441,000591,000448,000503,000396,000566,000454,000430,000367,000418,000433,000419,000352,000478,000368,000379,000399,000420,000368,000428,0001,378,000455,000414,000344,000366,000428,000000
       Other Current Liabilities 
0
0
0
1,084,000
1,005,000
1,008,000
1,212,000
941,000
34,000
847,000
877,000
1,053,000
1,171,000
1,050,000
1,192,000
1,263,000
1,361,000
1,137,000
857,000
973,000
1,160,000
1,292,000
1,998,000
2,350,000
2,722,000
2,613,000
2,485,000
3,822,000
4,393,000
4,211,000
4,534,000
-96,000
-361,000
-391,000
-643,000
-615,000
-347,000
-442,000
-610,000
-812,000
-359,000
-2,604,000
-3,103,000
-1,057,000
-509,000
-656,000
-879,000
-994,000
-620,000
-739,000
-694,000
-920,000
-651,000
2,728,000
1,449,000
6,015,000
1,947,000
2,583,000
-1,512,000
-4,228,000
3,707,000
-1,329,000
2,589,000
2,481,000
3,117,000
2,225,000
2,225,0003,117,0002,481,0002,589,000-1,329,0003,707,000-4,228,000-1,512,0002,583,0001,947,0006,015,0001,449,0002,728,000-651,000-920,000-694,000-739,000-620,000-994,000-879,000-656,000-509,000-1,057,000-3,103,000-2,604,000-359,000-812,000-610,000-442,000-347,000-615,000-643,000-391,000-361,000-96,0004,534,0004,211,0004,393,0003,822,0002,485,0002,613,0002,722,0002,350,0001,998,0001,292,0001,160,000973,000857,0001,137,0001,361,0001,263,0001,192,0001,050,0001,171,0001,053,000877,000847,00034,000941,0001,212,0001,008,0001,005,0001,084,000000
   > Long-term Liabilities 
0
0
0
3,126,000
2,862,000
2,642,000
2,551,000
2,261,000
2,793,000
2,784,000
2,792,000
2,653,000
2,572,000
2,581,000
1,167,000
426,000
446,000
453,000
421,000
329,000
333,000
1,390,000
763,000
567,000
453,000
333,000
307,000
1,533,000
1,238,000
898,000
464,000
630,000
449,000
465,000
453,000
673,000
656,000
674,000
665,000
643,000
640,000
666,000
657,000
877,000
1,124,000
1,048,000
1,030,000
1,114,000
1,374,000
1,491,000
1,415,000
1,359,000
1,292,000
3,086,000
19,328,000
18,834,000
18,835,000
18,759,000
18,759,000
14,549,000
14,548,000
14,635,000
19,591,000
19,927,000
20,112,000
21,243,000
21,243,00020,112,00019,927,00019,591,00014,635,00014,548,00014,549,00018,759,00018,759,00018,835,00018,834,00019,328,0003,086,0001,292,0001,359,0001,415,0001,491,0001,374,0001,114,0001,030,0001,048,0001,124,000877,000657,000666,000640,000643,000665,000674,000656,000673,000453,000465,000449,000630,000464,000898,0001,238,0001,533,000307,000333,000453,000567,000763,0001,390,000333,000329,000421,000453,000446,000426,0001,167,0002,581,0002,572,0002,653,0002,792,0002,784,0002,793,0002,261,0002,551,0002,642,0002,862,0003,126,000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
471,000
455,000
433,000
449,000
430,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000430,000449,000433,000455,000471,000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,473,000
1,809,000
0
0
0
0
0
0
0
0
0
0000000001,809,0002,473,0000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
2,850,000
2,879,000
3,080,000
3,122,000
3,452,000
3,522,000
3,774,000
3,987,000
4,478,000
4,440,000
4,968,000
5,398,000
6,042,000
5,921,000
6,350,000
6,155,000
6,769,000
6,090,000
5,847,000
5,423,000
6,283,000
5,395,000
6,473,000
5,793,000
4,706,000
4,026,000
4,923,000
4,499,000
5,068,000
4,214,000
5,064,000
4,958,000
5,952,000
4,711,000
5,376,000
5,202,000
6,418,000
5,192,000
6,173,000
5,939,000
6,913,000
5,451,000
6,586,000
6,362,000
7,406,000
5,770,000
6,936,000
6,927,000
8,168,000
6,419,000
7,273,000
8,292,000
5,905,000
7,034,000
6,490,000
6,490,000
17,299,000
15,125,000
16,200,000
16,524,000
17,942,000
15,461,000
16,942,000
16,942,00015,461,00017,942,00016,524,00016,200,00015,125,00017,299,0006,490,0006,490,0007,034,0005,905,0008,292,0007,273,0006,419,0008,168,0006,927,0006,936,0005,770,0007,406,0006,362,0006,586,0005,451,0006,913,0005,939,0006,173,0005,192,0006,418,0005,202,0005,376,0004,711,0005,952,0004,958,0005,064,0004,214,0005,068,0004,499,0004,923,0004,026,0004,706,0005,793,0006,473,0005,395,0006,283,0005,423,0005,847,0006,090,0006,769,0006,155,0006,350,0005,921,0006,042,0005,398,0004,968,0004,440,0004,478,0003,987,0003,774,0003,522,0003,452,0003,122,0003,080,0002,879,0002,850,000000
   Common Stock
0
0
0
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
228,000
228,000
228,000
228,000
228,000
228,000
228,000
228,000228,000228,000228,000228,000228,000228,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-3,075,000
0
0
0
0
0
0
0
-3,436,000
0
0
0
-3,703,000
0
26,000
77,000
-3,856,000
-43,000
-139,000
-183,000
-3,993,000
-205,000
-138,000
-200,000
-4,341,000
-5,000
4,000
-78,000
-4,672,000
-84,000
-69,000
-7,000
-4,804,000
-45,000
-110,000
-167,000
-5,191,000
-135,000
-165,000
-134,000
-5,463,000
-246,000
-293,000
-278,000
-5,736,000
-322,000
-425,000
-400,000
-433,000
-465,000
-187,000
-370,000
-495,000
-762,000
-816,000
-1,603,000
-1,156,000
-1,038,000
-1,477,000
-1,324,000
0
0
0
000-1,324,000-1,477,000-1,038,000-1,156,000-1,603,000-816,000-762,000-495,000-370,000-187,000-465,000-433,000-400,000-425,000-322,000-5,736,000-278,000-293,000-246,000-5,463,000-134,000-165,000-135,000-5,191,000-167,000-110,000-45,000-4,804,000-7,000-69,000-84,000-4,672,000-78,0004,000-5,000-4,341,000-200,000-138,000-205,000-3,993,000-183,000-139,000-43,000-3,856,00077,00026,0000-3,703,000000-3,436,0000000000-3,075,000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
3,326,000
-44,000
-60,000
-128,000
-21,000
-44,000
34,000
40,000
3,404,000
-99,000
-63,000
-72,000
3,663,000
34,000
634,000
77,000
5,275,000
-86,000
-139,000
-366,000
5,351,000
-410,000
-138,000
-400,000
5,971,000
-10,000
955,000
-156,000
6,540,000
-168,000
-69,000
-14,000
7,001,000
-90,000
-110,000
-334,000
7,330,000
-270,000
-165,000
-268,000
7,784,000
-492,000
-293,000
-556,000
8,186,000
-644,000
-425,000
-800,000
-433,000
-930,000
-187,000
2,690,000
-2,882,000
246,000
-1,360,000
-3,206,000
-1,156,000
-2,076,000
1,125,000
-1,324,000
2,323,000
-1,285,000
429,000
429,000-1,285,0002,323,000-1,324,0001,125,000-2,076,000-1,156,000-3,206,000-1,360,000246,000-2,882,0002,690,000-187,000-930,000-433,000-800,000-425,000-644,0008,186,000-556,000-293,000-492,0007,784,000-268,000-165,000-270,0007,330,000-334,000-110,000-90,0007,001,000-14,000-69,000-168,0006,540,000-156,000955,000-10,0005,971,000-400,000-138,000-410,0005,351,000-366,000-139,000-86,0005,275,00077,000634,00034,0003,663,000-72,000-63,000-99,0003,404,00040,00034,000-44,000-21,000-128,000-60,000-44,0003,326,000000



6.3. Balance Sheets

Currency in DKK. All numbers in thousands.




6.4. Cash Flows

Currency in DKK. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in DKK. All numbers in thousands.

Gross Profit (+$)
totalRevenue27,030,000
Cost of Revenue-8,761,000
Gross Profit18,269,00018,269,000
 
Operating Income (+$)
Gross Profit18,269,000
Operating Expense-10,949,000
Operating Income7,320,0007,320,000
 
Operating Expense (+$)
Research Development913,000
Selling General Administrative1,244,000
Selling And Marketing Expenses8,825,000
Operating Expense10,949,00010,982,000
 
Net Interest Income (+$)
Interest Income155,000
Interest Expense-795,000
Other Finance Cost-85,000
Net Interest Income-725,000
 
Pretax Income (+$)
Operating Income7,320,000
Net Interest Income-725,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)6,395,0008,245,000
EBIT - interestExpense = 6,395,000
6,395,000
5,847,000
Interest Expense795,000
Earnings Before Interest and Taxes (EBIT)7,190,0007,190,000
Earnings Before Interest and Taxes (EBITDA)8,480,000
 
After tax Income (+$)
Income Before Tax6,395,000
Tax Provision-1,343,000
Net Income From Continuing Ops5,052,0005,052,000
Net Income5,052,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses19,710,000
Total Other Income/Expenses Net-925,000725,000
 

Technical Analysis of Coloplast
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Coloplast. The general trend of Coloplast is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Coloplast's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Coloplast Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Coloplast A/S.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 82.36 < 86.56 < 87.50.

The bearish price targets are: 80.76.

Know someone who trades $CBHD? Share this with them.πŸ‘‡

Coloplast A/S Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Coloplast A/S. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Coloplast A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Coloplast A/S. The current macd is -1.40322074.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Coloplast price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Coloplast. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Coloplast price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Coloplast A/S Daily Moving Average Convergence/Divergence (MACD) ChartColoplast A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Coloplast A/S. The current adx is 23.35.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Coloplast shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Coloplast A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Coloplast A/S. The current sar is 86.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Coloplast A/S Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Coloplast A/S. The current rsi is 38.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Coloplast A/S Daily Relative Strength Index (RSI) ChartColoplast A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Coloplast A/S. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Coloplast price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Coloplast A/S Daily Stochastic Oscillator ChartColoplast A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Coloplast A/S. The current cci is -129.33799158.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Coloplast A/S Daily Commodity Channel Index (CCI) ChartColoplast A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Coloplast A/S. The current cmo is -26.84208926.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Coloplast A/S Daily Chande Momentum Oscillator (CMO) ChartColoplast A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Coloplast A/S. The current willr is -70.28753994.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Coloplast is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Coloplast A/S Daily Williams %R ChartColoplast A/S Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Coloplast A/S.

Coloplast A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Coloplast A/S. The current atr is 1.5242555.

Coloplast A/S Daily Average True Range (ATR) ChartColoplast A/S Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Coloplast A/S. The current obv is -15,392.

Coloplast A/S Daily On-Balance Volume (OBV) ChartColoplast A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Coloplast A/S. The current mfi is 51.21.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Coloplast A/S Daily Money Flow Index (MFI) ChartColoplast A/S Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Coloplast A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Coloplast A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Coloplast A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.346
Ma 20Greater thanMa 5084.727
Ma 50Greater thanMa 10087.868
Ma 100Greater thanMa 20094.968
OpenGreater thanClose82.320
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Coloplast with someone you think should read this too:
  • Are you bullish or bearish on Coloplast? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Coloplast? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Coloplast A/S

I send you an email if I find something interesting about Coloplast A/S.


Comments

How you think about this?

Leave a comment

Stay informed about Coloplast A/S.

Receive notifications about Coloplast A/S in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.